To access this element change to forms mode OFF
Grant Award View - GA29959
Developing better preclinical screens for cardiotoxic drugs
GA ID:
GA29959
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
25-Oct-2018
Publish Date:
21-Dec-2018
Category:
Medical Research
Grant Term:
1-Jan-2019 to 31-Dec-2021
Value (AUD):
$498,767.50
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 17/18 1.1 Health and Medical Research
Grant Program:
Project
Grant Activity:
Developing better preclinical screens for cardiotoxic drugs
Purpose:
Before new drugs come to market we need to ensure that they not only work but also do not have any unintended side effects. The current guidelines for screening new drugs for cardiac toxicity are based on measuring how drugs affect the timing of cardiac electrical signals. This assay is widely regarded as being too simplistic. Here, we will test whether a new assay based on analysis of how drugs affect the morphology of cardiac electrical signals will provide more accurate estimation of risk.
GO ID:
GO Title:
NHMRC Project Grant Scheme
Internal Reference ID:
GNT1164518
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of New South Wales
Recipient ABN:
57 195 873 179
Grant Recipient Location
Suburb:
Sydney
Town/City:
Sydney
Postcode:
2052
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW, Overseas
Postcode:
Multiple
Country:
AUSTRALIA, UNITED KINGDOM